NCT02152124View on ClinicalTrials.gov

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Acromegaly
Trial Locations (1)

9000

Ghent University Hospital, Department of Endocrinology, 9K12IE, Ghent

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT02152124 - Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism? | Biotech Hunter | Biotech Hunter